Let’s explore “Phosphorus — lab reference”

Screening measure, not a stand-alone treatment target.

Risk-based goals may be <100, <70, or <55 depending on primary/secondary prevention risk.

Higher HDL is not always protective; interpret within the entire risk profile.

150-199 borderline high; 200-499 high; ≥500 severe and pancreatitis-relevant.

Risk-based goals may be lower; useful when triglycerides are elevated.

Often calculated. Less reliable when triglycerides are markedly elevated.

90-99 above desirable; 100-119 borderline high; 120-139 high; ≥140 very high. Risk goals may be lower.

The test method matters. Ask your clinician to read this result with HDL and ApoB.

Approximate risk strata are sex-specific and assay-dependent.

≥75 increased; ≥125 commonly treated as a risk-enhancing level. Units are not directly interchangeable with mg/dL.

≥2 suggests higher cardiovascular risk; >10 may reflect acute inflammation and should generally be repeated when well.

Age, kidney function, obesity, rhythm, and clinical setting affect interpretation.